Stockscreener 앱 받기
30.30
0.98%
-0.30
시간 외 거래:
30.25
-0.05
-0.17%
전일 마감가:
$30.60
열려 있는:
$30.36
하루 거래량:
142.00K
Relative Volume:
2.33
시가총액:
$450.88M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+44.84%
1개월 성능:
+57.81%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$29.04
$30.94
1주일 범위
$20.90
$31.66
52주 변동 폭
$15.00
$31.66
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com UK
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Farallon Capital Management LLC Makes New $7.10 Million Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Farallon Capital Management LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com Canada
Tectonic Therapeutics stock earns continued Overweight rating on catalyst-packed 12 months ahead - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - MarketBeat
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com India
Tectonic reports positive Phase 1a results for heart treatment TX45 By Investing.com - Investing.com Australia
Tectonic Therapeutic reports findings from Phase Ia trial of TX45 - Yahoo Finance
Tectonic reports positive Phase 1a results for heart treatment TX45 - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High at $19.88 - MarketBeat
Tectonic Therapeutic’s TX45 Shows Promise in Phase 1a Trial - TipRanks
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Down to $18.65 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 2.9% - MarketBeat
Atlas Venture Life Science Advisors LLC Purchases New Stake in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 52.6% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $17.50 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 2.9% - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Up 50.4% in August - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Growth in Short Interest - Defense World
AVROBIO, Inc. announced that it has received $25.150002 million in funding from Atlas Venture L.P., SV Health Investors, LLC, Blackstone Life Sciences - Marketscreener.com
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024 - InvestorPlace
Contrasting SpringWorks Therapeutics (NASDAQ:SWTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $16.25 - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Tectonic stock wins bullish view at Wells Fargo (NASDAQ:TECX) - Seeking Alpha
Wells Fargo rates Tectonic Therapeutics shares Overweight, cites TX45's potential - Investing.com
Tectonic Therapeutic (NASDAQ:TECX) Research Coverage Started at Wells Fargo & Company - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Stock Quotes, Forecast and News Summary - Benzinga
Tectonic Therapeutic to Participate in September Investor Conferences - GlobeNewswire
Tectonic Therapeutic to Participate in September Investor Conferences - StockTitan
Tectonic Therapeutic to Participate in September Investor Conferences - Yahoo Finance
Q3 2024 Earnings Estimate for Tectonic Therapeutic Issued By Leerink Partnrs (NASDAQ:TECX) - MarketBeat
Leerink Partnrs Brokers Reduce Earnings Estimates for Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Large Volume Increase - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Strong Trading Volume - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 4.6% - MarketBeat
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan
Head to Head Contrast: Tectonic Therapeutic (TECX) & Its Competitors - Defense World
Reviewing VectivBio (NASDAQ:VECT) & Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.05%
4.86%
자본화:
|
볼륨(24시간):